Tinospora Cordifolia: Medicinal Plant: A Review

doi:10.5281/zenodo.8337144

International Journal of Medical and Pharmaceutical Research

2023, Volume-4, Special Issue 3 doi: 10.5281/zenodo.8337144

Review Article

Tinospora Cordifolia: Medicinal Plant: A Review

Prashant Singh

Sushil Kumar Tiwari

Shiwani Jaiswal

Karunakar Prasad Dwivedi

Shreya Maddhesiya

Navneet Kumar Verma

DOI : 10.5281/zenodo.8337144

Published

June 30, 2023

Abstract

Wild Tinospora cordifolia Guduchi/Amrita, native name; English: Indian Tinospora, also known as Giloya/Gulancha in Hindi, belongs to the Menispermaceae family and is abundant in Bangladesh, Myanmar, Sri Lanka, and China. The plant is a spreading and climbing shrub with many twisting branches. T. cordifolia is utilised in Ayurvedic medicine and has a variety of therapeutic characteristics. This page summarises the plant's chemical ingredients and pharmacological characteristics. The review will offer future researchers with a scientific basis for its usage in Ayurveda as well as an instructive database on an ethno-pharmacologically valuable medicinal plant.

Recommended Articles

Volume-4, Special Issue 3

Downloads

Download PDF pdf

Download XML

Citations

1072 Views

28 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.